DiaMedica Therapeutics Announces Non-Brokered Private Placement
(WorldNews Canada)

MINNEAPOLIS, Dec. 13, 2017 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the `Company`) (TSX-V:DMA) (OTCQB:DMCAF), announces that, subject to TSX Venture Exchange approval, it is undertaking a non-brokered private placement for gross proceeds of approximately CAD$1 million (approximately USD$780,000) with the issuance of 2,985,075 Units at an issue price of CAD$0.335 (USD$0.26) (the `Offering`). Each Unit consists of one common share and one-half of one common share purchase warrant, with each whole warrant entitling the holder thereof to acquire one additional common share at an exercise price of USD$0.35 (approximately CAD$0.45) per share until 5:00 p.m. (Central Time) on the date that...